<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> (CHI or HI) is a condition leading to <z:hpo ids='HP_0001988'>recurrent hypoglycemia</z:hpo> due to an inappropriate insulin secretion by the pancreatic islet beta cells </plain></SENT>
<SENT sid="1" pm="."><plain>HI has two main characteristics: a high <z:chebi fb="105" ids="17234">glucose</z:chebi> requirement to correct <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> and a responsiveness of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> to exogenous glucagon </plain></SENT>
<SENT sid="2" pm="."><plain>HI is usually isolated but may be rarely part of a <z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">genetic syndrome</z:e> (e.g. <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, <z:e sem="disease" ids="C0175695" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Sotos syndrome</z:e> etc.) </plain></SENT>
<SENT sid="3" pm="."><plain>The severity of HI is evaluated by the <z:chebi fb="105" ids="17234">glucose</z:chebi> administration rate required to maintain <z:mpath ids='MPATH_458'>normal</z:mpath> glycemia and the responsiveness to medical treatment </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0003623'>Neonatal onset</z:hpo> HI is usually severe while <z:hpo ids='HP_0003584'>late onset</z:hpo> and syndromic HI are generally responsive to a medical treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Glycemia must be maintained within <z:mpath ids='MPATH_458'>normal</z:mpath> ranges to avoid brain damages, initially with <z:chebi fb="105" ids="17234">glucose</z:chebi> administration and glucagon infusion then, once the diagnosis is set, with specific HI treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Oral <z:chebi fb="0" ids="4495">diazoxide</z:chebi> is a first line treatment </plain></SENT>
<SENT sid="7" pm="."><plain>In case of unresponsiveness to this treatment, somatostatin analogues and calcium <z:chebi fb="68" ids="48706">antagonists</z:chebi> may be added, and further investigations are required for the putative histological diagnosis: pancreatic (18)F-fluoro-<z:chebi fb="0" ids="15765">L-DOPA</z:chebi> PET-CT and molecular analysis </plain></SENT>
<SENT sid="8" pm="."><plain>Indeed, focal forms consist of a focal adenomatous <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> of islet cells, and will be cured after a partial pancreatectomy </plain></SENT>
<SENT sid="9" pm="."><plain>Diffuse HI involves <z:hpo ids='HP_0000001'>all</z:hpo> the pancreatic beta cells of the whole pancreas </plain></SENT>
<SENT sid="10" pm="."><plain>Diffuse HI resistant to medical treatment (octreotide, <z:chebi fb="0" ids="4495">diazoxide</z:chebi>, calcium <z:chebi fb="68" ids="48706">antagonists</z:chebi> and continuous feeding) may require subtotal pancreatectomy which post-operative outcome is unpredictable </plain></SENT>
<SENT sid="11" pm="."><plain>The genetics of focal islet-cells <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> associates a paternally inherited mutation of the ABCC8 or the KCNJ11 genes, with a loss of the maternal allele specifically in the hyperplasic islet cells </plain></SENT>
<SENT sid="12" pm="."><plain>The genetics of diffuse isolated HI is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and may be recessively inherited (ABCC8 and KCNJ11) or dominantly inherited (ABCC8, KCNJ11, GCK, GLUD1, SLC16A1, HNF4A and HADH) </plain></SENT>
<SENT sid="13" pm="."><plain>Syndromic HI are always diffuse form and the genetics depend on the syndrome </plain></SENT>
<SENT sid="14" pm="."><plain>Except for HI due to <z:chebi fb="120" ids="26216">potassium</z:chebi> channel defect (ABCC8 and KCNJ11), most of these HI are sensitive to <z:chebi fb="0" ids="4495">diazoxide</z:chebi> </plain></SENT>
<SENT sid="15" pm="."><plain>The main points sum up the management of HI: i) prevention of brain damages by normalizing glycemia and ii) screening for focal HI as they may be definitively cured after a limited pancreatectomy </plain></SENT>
</text></document>